Cargando…
Editorial: Advances in the understanding of pathogenesis, diagnosis, and therapy of light chain amyloidosis
Autores principales: | Bhutani, Divaya, Bal, Susan, Rubinstein, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998974/ https://www.ncbi.nlm.nih.gov/pubmed/36910666 http://dx.doi.org/10.3389/fonc.2023.1163490 |
Ejemplares similares
-
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023) -
Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis
por: Kaufman, Gregory P., et al.
Publicado: (2021) -
PB2151: CLINICAL FEATURES AND OUTCOMES OF DIFFUSE PULMONARY LIGHT CHAIN AMYLOIDOSIS: A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023) -
Real world data on light chain cardiac amyloidosis: Still a delayed diagnosis
por: Chatzileontiadou, Sofia, et al.
Publicado: (2022) -
Recent advances in understanding and treating immunoglobulin light chain amyloidosis
por: Badar, Talha, et al.
Publicado: (2018)